Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medication CEO Lars Fruergaard Jørgensen explained to lawmakers the corporation would look at new talks with insurers with regard to the list rates of Wegovy and copyright should they pledge to maintain the medicines on their own https://josueyuqlh.pages10.com/an-unbiased-view-of-healthcare-news-66202892